EQS-News: Rentschler Biopharma SE / Key word(s): Personnel Rentschler Biopharma appoints Robert Panting as VP Global Client Program Management and Strategy 20.03.2025 / 15:00 CET/CEST
EQS-News: Eckert & Ziegler SE / Key word(s): Incoming Orders/Agreement Eckert & Ziegler and AtomVie Global Radiopharma Sign a Global Agreement for Lutetium-177 Supply 20.03.2025
EQS-News: meliodays medical GmbH / Key word(s): Financing Meliodays Medical announces the closing of a pre-seed financing round of over EUR 800,000 20.03.2025 / 09:05
NEW YORK — In his first public comments, Pfizer’s new innovation chief — once a Wall Street analyst skeptical of the company — said he
The Food and Drug Administration cleared Alnylam Pharmaceuticals’ treatment for a progressive heart condition Thursday, setting it up to compete with therapies from BridgeBio and
On Wednesday, as S. was heading to the library to apply for yet more jobs, an email pinged onto her phone. The subject line said,
NEW YORK — Former Food and Drug Administration commissioner Scott Gottlieb criticized the current administration’s approach to containing a deadly measles outbreak as well as its
How do obesity biotechs compete against Novo Nordisk and Eli Lilly? Why does gene therapy pioneer Jim Wilson think there’s “irrational pessimism” in the field?
A new startup hoping to source the best therapies being developed in China and bring them stateside has secured early funding from Venrock and BVF
NEW YORK — To gene therapy pioneer Jim Wilson, the field is currently clouded with “irrational pessimism.” Companies are abandoning ship; approved therapies aren’t being